Posttranscriptional Regulation of Mammalian Methionine Synthase by B\u3csub\u3e12\u3c/sub\u3e by Gulati, Sumedha et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Biochemistry -- Faculty Publications Biochemistry, Department of 
July 1999 
Posttranscriptional Regulation of Mammalian Methionine 
Synthase by B12 
Sumedha Gulati 
University of Nebraska - Lincoln 
Lawrence C. Brody 
National Human Genome Institute, NIH, Bethesda, Maryland 
Ruma V. Banerjee 
University of Nebraska - Lincoln, rbanerjee1@unl.edu 
Follow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons 
Gulati, Sumedha; Brody, Lawrence C.; and Banerjee, Ruma V., "Posttranscriptional Regulation of 
Mammalian Methionine Synthase by B12" (1999). Biochemistry -- Faculty Publications. 20. 
https://digitalcommons.unl.edu/biochemfacpub/20 
This Article is brought to you for free and open access by the Biochemistry, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biochemistry -- Faculty 
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Biochemical and Biophysical Research Communications 259,436-442 (1999) 
Article ID bbrc.1999.0696, available online a t  http:llwww.idealibrary.com on I D  E b ~ @  JI 
Posttranscriptional Regulation of Mammalian 
Methionine Synthase by B,, 1 
Sumedha G ~ l a t i , " , ~  Lawrence C. Brody,"fnd Ruma Bane~jee* ,~  
"Biochemistry Department, University of Nebraska, Lincoln, Nebraska 68588-0664; and ?Genetics and 
Molecular Biology Branch, National Human Genome Institute, NIH, Bethesda, Maryland 20892-4442 
Received April 12, 1999 
Methionine synthase is one of two key enzymes in- 
volved in the removal of the metabolite, homocysteine. 
Elevated homocysteine levels constitute a risk factor 
for cardiovascular diseases and for neural tube de- 
fects. In cell culture, the activity of methionine syn- 
thase is enhanced several-fold by supplementation 
with its cofactor, B,,. The mechanism of this regula- 
tion is unknown, although it has been ascribed to a 
shift from apoenzyme to holoenzyme. Using sensitive 
assay techniques as well as a combination of Northern 
and Western analyses, we demonstrate that the effect 
of B,, on induction of methionine synthase activity is 
paralleled by an increase in the level of the enzyme. 
These studies exclude conversion of apoenzyme to ho- 
loenzyme as a basis for activation that had been de- 
scribed previously. Since the mRNA levels do not 
change during the same period that the methionine 
synthase levels increase, regulation of this protein by 
its cofactor must be exerted posttranscriptionally. 
0 1999 Academic Press 
Methionine synthase is one of two key enzymes at 
the homocysteine metabolic junction in mammalian 
cell physiology. Its action converts homocysteine, a 
toxic metabolite to methionine, and concomitantly 
releases the circulating form of folic acid, methyl- 
tetrahydrofolate (CH,-H,folate), to tetrahydrofolate 
(H,folate), that is then available for supporting DNA 
biosynthesis (1,2). Elevated levels of homocysteine con- 
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stitute an independent and significant risk factor for 
cardiovascular diseases (3). In addition, elevated levels 
of homocysteine and low maternal levels of BIZ are 
correlated with neural tube defects (4,5). Methionine 
synthase is thus an important housekeeping enzyme at 
the intersection of sulfur and one-carbon metabolism, 
and its regulation influences intracellular homocys- 
teine and folate pools. The consequences of lowering 
homocysteine with vitamins are being measured in 
clinical intervention studies. Thus, elucidating the 
mechanism by which BIZ induces methionine synthase 
activity and thereby affects homocysteine pools may 
have an important bearing on these intervention 
studies. 
Studies by Mangum and North almost thirty years 
ago on the regulation of mammalian methionine syn- 
thase in HEp-2 cells in culture revealed that supple- 
mentation of the medium with BIZ resulted in a thirty- 
fold elevation of enzyme activity (6). This was later 
extended to several other cell lines in which the BIZ- 
induced activation of methionine synthase ranged from 
10- to 30-fold (7). In the initial experiments, homocgs- 
teine and vitamin BIZ replaced methionine and choline 
in the medium. Homocysteine was however found to 
have no effect on the activation of methionine syn- 
thase, since BIZ in the presence or absence of homocys- 
teine yielded the same extent of stimulation (7). The 
activity of the only other mammalian BIZ-dependent 
enzyme, methylmalonyl-CoA mutase, was unchanged 
upon supplementation of the medium with BIZ (8). 
Several alternative hypotheses can be considered to 
explain induction of methionine synthase activity by 
its cofactor, BIZ. First, if intracellular BIZ concentration 
is limiting, increase in enzyme activity could be due to 
conversion of apoenzyme to holoenzyme. Second, BIZ 
may exert its regulation at the methionine synthase 
promoter resulting in increased transcription. Third, 
BIZ may enhance translation of the methionine syn- 
thase mRNA, either by affecting the stability of the 
message or by increasing access of the message to the 
translation apparatus. Fourth, B1, may enhance the 
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stability of methionine synthase thereby affecting its 
turnover in the cell. Finally, B,, may induce one or 
more genes that in turn increases the level of methio- 
nine synthase either at a transcriptional or post- 
transcriptional level. 
The recent cloning of the human methionine syn- 
thase cDNA (9-11) and the development of sensitive 
assays to measure the relative apo- and holoenzyme 
content of the enzyme (12-14) now permit evaluation 
of these alternative hypotheses. In this study, we have 
examined whether the induction of methionine syn- 
thase by B,, is correlated with changes in the mRNA 
levels, protein levels or the percent holoenzyme. Our 
studies clearly point to a post-transcriptional mecha- 
nism of activation of methionine synthase that is de- 
pendent on the synthesis of new enzyme. 
MATERIALS AND METHODS 
Materials. EMEM and hydroxocobalamin were purchased from 
Sigma. Fetal calf serum was from Calbiochem. The RNeasy kit was 
from Qiagen and Hybond N+ membrane was from Amersham. 
RNase free reagents (MOPS, SSC) were molecular biology grade and 
were purchased from 5 Prime-3 Prime. DEPC treated water was 
used for making up solutions for RNA studies. Cell lines, Cos-7 
(SV4O-transformed African Green Monkey kidney cells), HeLa (hu- 
man cervical carcinoma cells), HepG2 (human hepatoblastoma cells), 
and 293 (transformed human kidney cells) cells were from ATCC, 
and 293 t' (derivative of 293 expressing the T antigen) was from 
Mike Fudos (NIH). The actin probe was from an in vitro transcrip- 
tion kit from Ambion. 
Cell culture. Cells were cultured in EMEM supplemented with 
10% fetal bovine serum and maintained a t  37"C, 5% CO,. The con- 
centration of folic acid and methionine in  this medium are 2.3 pM 
and 100 pM respectively. The estimated concentration of BIZ in the 
unsupplemented medium is -125 pM, and is derived from the serum 
(15). For studies involving RNA isolation, confluent cells from 4 or 5 
petri dishes (150 mm) were harvested and frozen in lysis solution 
and stored a t  -80°C until further processing. 
For studies involving protein analysis (enzyme assays or Western 
blots) cell monolayers were washed with PBS, collected by centrifu- 
gation and the pellet was washed twice with PBS prior to freezing a t  
-80°C. For B,, induction studies, cells were grown to subconfluency 
before replacement of the medium with fresh EMEM supplemented 
with OHBIZ a t  a concentration of 5 mg/L. The BIZ concentration was 
chosen based on the dose response for methionine synthase activity 
that has been reported previously (15). For experiments in  which 
methionine synthase activity, and protein and RNA levels were 
being determined simultaneously a t  fixed time points following BIZ 
addition (0, 24, and 48 h), a large number of plates were cultured in 
parallel. Cells from 3 or 4 petri dishes were used per time point for 
each of the protein and RNA determinations. 
Methionine synthase assay using cell extracts. The cell extracts 
were prepared and anaerobic assays were performed essentially as 
described previously (13). The cell extracts for the assays were 
thawed immediately prior to their use. They were made anaerobic by 
gently passing N, for 30 min over the extracts in 1.5 ml eppendorf 
tubes sealed with red rubber septa. The amount of protein used in 
the assays ranged from 0.3 mg to 0.6 mg. Protein concentrations 
were determined using the Bradford assay (BioRad) with bovine 
serum albumin as  standard. One unit of activity is defined as  the 
amount of protein required to synthesize one pmol of methionine h-' 
a t  37°C. 
RNA isolation. RNA was isolated using the RNeasy kit as  per the 
vendor's protocol (Qiagen). Aliquots (20-30 pl) of RNA were stored a t  
-80°C until needed. 
Northern analysis. RNA samples (10-15 pg) were heated a t  65°C 
for 5 min and then cooled immediately on ice prior to loading onto a 
1% formaldehyde agarose gel. The gel was electrophoresed in RNase 
free 1X MOPS (25 volts for -20 h a t  4"C), equilibrated with 10X SSC 
and transferred to a Hybond N+ membrane in the same buffer. After 
overnight transfer, RNA was UV-linked to the membrane. Prehy- 
bridization and hybridizations were performed in Church and Gil- 
bert hybridization buffer. Hybridization was conducted overnight a t  
65°C for 12 h (with 3 x lo6 dpm per ml radiolabeled probe). An 
NcoI-EcoRI fragment containing the homocysteine-binding domain 
in plasmid SGHcy-28a (described below) was used as  one of the 
probes. Probes (for methionine synthase and actin) were radiolabeled 
with 32P (Rediprime kit from Amersham Life Science). Following 
hybridization, the membrane was washed a t  65°C for 3 x 20 min 
with 2X SSC and 0.1% SDS. The membrane was exposed to a phos- 
phoimager screen for 2-3 days a t  room temperature and then 
scanned. 
Cloning and expression of homocysteine binding domain of human 
MS. The N-terminal region of human methionine synthase extend- 
ing from amino acids 1 to 368 is homologous to the homocysteine 
binding domain of the E. coli protein ranging from residues 2-353 
(16,17). The segment of the human cDNA encoding this fragment 
was amplified by PCR and cloned using the primers described below. 
An NcoI site and an EcoRI site were engineered into the 5' sense and 
3' antisense primers respectively and are indicated in  bold letters in  
the primer sequences shown below. 5' sense: 5' CATGCCAXGG- 
CTCCGGCGCTGCAGGACCTGTCGC 3'. 3' antisense: 5' GAATTC- 
AATGlTAACAAAlTACTAGTACGGTCCAATCCT 3'. In the 5' primer, 
the E. coli codon preference was employed at  some locations to 
potentially enhance translation efficiency. The codon preference for 
amino acids following the initiator methionine codon located within 
the NcoI site (underlined in primer sequence) are indicated in pa- 
rentheses: Met-Ala (E. coli)-Pro (E. co1i)-Ala (human)-Leu (E. co1i)- 
Gln (E. co1i)-Asp (human)-Leu (human)-Ser (human). In the 3' 
primer, two tandem stop codons (underlined) were engineered into 
the sequence after residue 368 encoding tyrosine. A 1.1 kb fragment 
was amplified by PCR using Klentaq polymerase (Clonetech) and 
cDNA from human pancreas (Clonetech) as  template. The amplified 
band was initially cloned into the TA vector, PCR 2.1, from Invitro- 
gen, and the ligation mixture was used to transform E. coli Top10 F' 
cells (Invitrogen). DNA from a single colony was digested with NcoI 
and EcoRI and the fragment was cloned into the pet 28 a expression 
vector (Novagen) to create SGHcy-28a, and transformed into BL21 
DE3. The DNA sequence of the insert in SGHcy-28a was determined. 
Expression of homocysteine binding domain of human methionine 
synthase. A colony containing plasmid SGHcy-28a with the 1.1 kb 
insert, was grown overnight in  2 ml LB medium (containing 50 pglml 
kanamycin) which was used to inoculate a 50 ml LBkanamycin 
culture the next day. The culture was grown a t  37°C to an O.D,,, of 
0.5-0.6 (-3 h) and expression was induced with 0.8 mM IPTG for 3 h. 
Cells were collected by centrifugation and the pellet was resus- 
pended in 3 ml of 50 mM Tris-HC1 pH 8.0,2 mM EDTA. The soluble 
and insoluble cell fractions were obtained using a protocol from 
Novagen. Lysozyme a t  a concentration of 100 pglml and 0.1 volume 
of 1% Triton X-100 (Bio-Rad) were added to the resuspended pellet 
and incubated a t  30°C for 15 min. This was followed by centrifuga- 
tion at  12,000 X g for 15 min a t  4°C. The soluble (supernatant) and 
insoluble (pellet) fractions were resuspended in a 1X SDS sample 
loading buffer (Bio-Rad) containing P-mercaptoethanol, and sepa- 
rated by electrophoreses on a 10% SDS polyacrylamide gel (Figure 
3A). The identity of the recombinant 37 kDa band was confirmed by 
N-terminal amino acid sequence analysis and by Western analysis 
using antibodies generated against porcine methionine synthase 
(12). DNA and N-terminal sequence analyses revealed that Glu 12 
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TABLE I 








Specific activity Specific activitya 
-BIZ +Biz %Holo -BIZ +Biz %Holo Fold increaseb 
" Specific activity is expressed in pmol methionine formed min-' mg-' a t  37°C. 
The fold increase was estimated by comparing the values for specific activities measured in the presence of added BIZ. 
was deleted. This could have resulted from a polymorphism a t  this 
position that was present in the cDNA library or, more likely, from a 
PCR error. 
Generation of antibodies against the human methionine synthase. 
The pellet containing the insoluble N-terminal domain of human 
methionine synthase was washed extensively with 50 mM Tris, pH 
8.0 containing 2 mM EDTA. The washed pellet (-1.5 mg) was sep- 
arated on a preparative 7% SDS polyacrylamide gel and the band of 
interest was excised after staining with Coommasie brilliant blue 
R-250 (Bio-Rad) followed by extensive destaining. The excised band 
was sent to a commercial antibody facility (Alpha Diagnostics, 
Texas) for generation of polyclonal antibodies in  rabbits. 
Western analysis of human methionine synthase in cells cultured in 
medium ? B,,. Extracts (50 bg protein), from cells grown in EMEM 
medium supplemented with B,, for 0.24 and 48 h. were separated on 
a 5% SDS ~olyacrylamide geir The 'proteins were transferred to a 
PVDF membranes using a tank electroblotter for 6 h a t  100 V. 
Western analysis was performed using a 1:100 dilution of the first 
antibody and a 1:5000 dilution of the second antibody, anti-rabbit 
IgGIalkaline phosphatase conjugate (BioRad), followed by chemilu- 
minescent detection using the CDP-Starr kit (Tropix). Chemilumi- 
nescent signals were quantitated using a Molecular Dynamics den- 
sitometer. 
RESULTS 
Induction of methionine synthase activity by Biz is 
not due to apoenzyme to holoenzyme conversion. In 
order to examine whether or not activation by B,, is 
due to conversion of apoenzyme to holoenzyme, the 
effect of B,, addition to the cell culture medium was 
examined in five different cell lines (Table I). Enzyme 
activity was measured in the anaerobic titanium ci- 
trate assay either in the presence or absence of exoge- 
nous B,,. Activity determined in the presence of B12 
represents total methionine synthase activity. In the 
absence of B,,, only holoenzyme activity is measured. 
Thus the ratio of activity observed in the absence to 
that in the presence of additional cofactor represents 
the proportion of holoenzyme present. As shown in 
Table I, all five cells lines showed stimulation of me- 
thionine synthase activity when the medium was sup- 
plemented with B,,. The fold increase varied with the 
cell line, ranging from 2-fold in HeLa cells to - 14-fold 
in HepG2 cells. Increasing the concentration of the 
cofactor ten-fold did not further increase the fold- 
induction (data not shown). Comparison of enzyme ac- 
tivity from cells that had been supplemented with B,, 
with those grown in unsupplemented media show that 
the proportion of holoenzyme remained the same, 
within experimental error. The only exception was 
293t' cells where the holoenzyme content increased 
from 34% to 100%. However, the 3-fold increase in 
percent holoenzyme does not account for the almost 
6-fold increase in methionine synthase activity result- 
ing from B,, supplementation. 293 cells were employed 
for the remainder of the studies described below be- 
cause of their high holoenzyme content and rapid 
growth rate. 
Kinetics of methionine synthase induction by B,,. 
The time course for the activation of methionine syn- 
thase was examined next. As shown in Figure 1, in- 
crease in methionine synthase activity could be ob- 
served as early as two hours following B,, addition. The 
activity increased rapidly during the first six hours 
reaching a plateau in -24 to 48 h and was sustained 
until 72 h. 
B,, supplementation does not change methionine syn- 
thase RNA levels. To examine whether the B,, effect 
is due to transcriptional activation of the methionine 
synthase gene, mRNA levels were analyzed 0, 24 and 
48 h after addition of the cofactor (Figure 2A). Two 
methionine synthase mRNA's of -10 and 7.5 kb sizes 
were observed by Northern analysis as has been re- 
ported previously (9,ll). However, the level of methio- 
nine synthase mRNA remained unchanged during the 
same period that a 2.5-fold increase in enzyme activity 
was observed. Equal loading of RNA in the three lanes 
was confirmed by probing for the actin message (Figure 
2B). Northern analysis of three other cell lines (COST, 
HepG2 and 293t') also revealed that the methionine 
synthase mRNA levels do not change upon B,, supple- 
mentation (data not shown). 
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FIG. 2. Northern blot analysis of RNA from 293 cells, 0, 24, and 
48 h after addition of B,,. RNA was isolated and detected by North- 
ern blot analysis as described under Materials and Methods. (A) Two 
bands corresponding to the -10 kb and 7.5 kb methionine synthase 
cDNA forms were observed. (B) To confirm equal loading of RNA in 
the lanes, the blot was later probed for the actin message. 
FIG. 1. Kinetics of methionine synthase induction in 293 cells by 
B,,. cells were grown to subconfluency in 150 mm petridishes as number of nutrients function as cofactors or substrates a t  
described under Materials and Methods. The medium was aspirated the homocysteine metabolic junction. Cystathionine 
off and replaced with fresh EMEM with either ? B,,. The cells were P+,pthase is a vitamin B,- and heme-dependent enzyme 
harvested by scraping at the indicated time points and frozen until whereas met.onine synthase requires both B,, and a 
further analysis. Methionine synthase activity was determined in 
the anaerobic titanium citrate assay in the absence of additional folate derivative, CH,-H,folate, for activity. This has re- 
cobalamin. The time points were repeated in either duplicate or cently led to the promotion of a multivitamin tablet con- 
triplicate, and standard errors are indicated. taining B,, BIZ, and folic acid as a '%omocysteine defense" 
Western analysis of methionine synthase levels in cell 
cultures exposed to B,,. Cell extracts from the 0, 24 
and 48 h time points were analyzed by Western blot- 
ting. As shown in Figure 3B, an increase in methionine 
synthase level is observed between the 0 and 24 h time 
points, while the difference between the 24 and 48 h 
time points is negligible. To ensure equal loading, the 
membrane was also exposed to antibody generated 
against the P. shermanii methylmalonyl-CoA mutase. 
As expected, the levels of this protein did not exhibit a 
time dependent change (Figure 3B lower panel). An 
additional lower band also crossreacted with the mu- 
tase antibody. Although its identity is unknown (it may 
be a proteolytic form), it serves as an additional control 
to demonstrate that a specific increase in methionine 
synthase levels is observed on supplementation of the 
medium with B,,. 
DISCUSSION B 
Elevated concentrations of homocysteine are corre- 
lated with risk for two apparently unrelated pathologies: 
cardiovascular diseases (3) and neural tube defects (5). In 
mammalian cells, two major enzymatic routes detoxify 
homocysteine. Transmethylation, catalyzed by either me- 
thionine synthase or betaine homocysteine methyltrans- 
ferase, salvages homocysteine to the AdoMet-dependent 
methylation cycle. Transsulfuration, catalyzed by cysta- 
thionine P-synthase converts homocysteine to cystathi- 
onine, and represents the first step in its catabolic re- 
moval. Due to the limited tissue distribution of betaine 
homocysteine methyltransferase in the liver and kidney 
(18), methionine synthase is the major transmethylase. A 
FIG. 3. Overexpression of human methionine synthase fragment 
and Western analysis of methionine synthase at various time points 
following addition of Biz. (A) Overexpression of the homocysteine- 
binding domain of human methionine synthase. Cell extracts con- 
taining SGHcy-28a were prepared as described under Materials and 
Methods. Lane 1 has low molecular weight markers, lane 2 has cell 
extract after sonication, lanes 3 and 4 have the soluble and insoluble 
fractions respectively separated from the cell extract. (B) Western 
analysis of methionine synthase levels in the 293 cell extracts at the 
indicated time points. As a control, the membrane was also probed 
with antibodies generated against methylmalonyl-CoA mutase from 
Propionibacterium shermanii. The band indicated by an arrow cor- 
responds to the human mutase. MS refers to methionine synthase. 
The sizes of the molecular weight markers (in kDa) are indicated on 
the left. 
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formula, and to folic acid fortification of flour in the U.S. 3.0 
in an effort to reduce the incidence of neural tube defects. 
Homocysteine lowering intervention studies using differ- 2.5 
ent vitamin regimens are either imminent or ongoing in 
several countries. 
Understanding the role of cofactors in regulating the .$ 2.0 j 
activities of enzymes at the homocysteine metabolic 
junction is therefore of importance from a clinical a .i 1.5 
- 
standpoint. One of these cofactors, B,,, was described 2 
thirty years ago, to induce activity of methionine syn- 1 .o 
thase in cell culture (6). In this study we have also 
observed that B,,-induces a 2 to 14-fold increase in 
methionine synthase activity in different cell lines. The 0.5 
mechanism by which exogenous B,, in the cell culture 
medium causes an increase in methionine synthase 
activity was previously unknown, although it had been 
ascribed to conversion of preexisting apoenzyme to ho- 
loenzyme (8,15). 
However, evaluation of the percent holomethionine 
synthase is complicated by its existence in multiple 
oxidation states, containing B,, as methylcob(II1)- 
alamin, hydroxycob(III)alalmin or cob(I1)alamin. Of 
these, only the first is active under in  vitro assay con- 
ditions, and then only, for a limited number of turn- 
overs (100-2000 depending on the degree of anaerobio- 
city (19,20)). This results from the oxidative sensitivity 
of the cofactor intermediate, cob(I)alamin, under cata- 
lytic turnover conditions. The oxidized forms of the 
enzyme can be reactivated in the presence of a one 
electron donor and S-adenosylmethionine. The stan- 
dard in  vitro assay employs dithiothreitol and OHB,, 
as a source of electrons. In the absence of OHB,,, di- 
thiothreitol is unable to transfer electrons to methio- 
nine synthase (21). The problem with this assay arises 
from its dependence on OHB,,, which serves both to 
transfer electrons from dithiothreitol to activate oxi- 
dized holoenzyme and binds to apoenzyme, eventually 
converting it to holoenzyme (12). Thus, the complexity 
of the methionine synthase assay has resulted in sig- 
nificant underestimation of the holoenzyme content in 
the literature. 
This problem is addressed by employing titanium 
citrate as the electron donor since it can directly reduce 
methionine synthase (12). Under these assay condi- 
tions, the relative content of apo- and holoenzyme can 
be evaluated by measuring activity in the presence and 
absence of exogenous OHB,,. Using this assay, we 
demonstrate that the increase in methionine synthase 
activity is not correlated with conversion of apoenzyme 
to holoenzyme (Table I). In fact in four of the five cell 
lines, addition of B,, to the cell culture medium does 
not affect the level of holomethionine synthase at all. 
One exception, 293t' cells, show a 3-fold increase in 
holoenzyme under these conditions, although this is 
insufficient to account for the 5.7-fold increase ob- 
served in methionine synthase activity. These results 
necessitate evaluation of alternative mechanisms to 
FIG. 4. Comparison of the methionine synthase activity and 
RNA and protein levels a t  the indicated time points following addi- 
tion of B,, to the medium. 
account for B,, induction of methionine synthase 
activity. 
The recent cloning of the human methionine syn- 
thase cDNA permits direct evaluation of the mRNA 
levels as a function of time following exposure to B,,. In 
order to choose appropriate time points for this analy- 
sis, the kinetics of methionine synthase induction were 
studied in the 293 cell line. As shown in Figure 1, 
maximal activation is observed in -24 h, and this level 
is sustained up to 72 h. This is very similar to the 
kinetics reported in cultured BHK cells (15). Based on 
these data, we compared the mRNA and protein levels 
at 0, 24 and 48 h following B,, addition to the cell 
culture medium (Figure 3). Comparison of the ratio of 
methionine synthase mRNA to actin mRNA indicates 
that the level of the methionine synthase mRNA re- 
mains fairly constant over 48 h (Figure 4) during which 
time enzyme activity increases 2.5-fold. The two RNA 
bands that hybridize to the methionine synthase probe 
have been observed previously (9,ll). The shorter 
cDNA has been sequenced completely (9). The 10 kb 
band is apparently a preprocessed form of the 7.5 kb 
message, since it hybridizes to a probe complementary 
to intron 5 (11). 
Since activation of methionine synthase levels was 
reported to be due to conversion of apoenzyme to ho- 
loenzyme we have directly estimated the relative levels 
of methionine synthase protein in the presence and 
absence of added B,,. As seen in Figures 3B and 4, an 
increase in the steady-state concentration of methio- 
nine synthase parallels the increase in its activity. It 
was previously reported that B,, induction of methio- 
nine synthase activity was not affected by the presence 
of the translation inhibitor, puromycin, added simulta- 
neously with B,, to the cell culture medium (15). How- 
ever, these results were inconsistent with the kinetics 
of B,, activation in the BHK cell lines reported in the 
same paper, since in the presence of puromycin, full 
activation was observed in 12 h rather than in 24 h. 
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Additionally, B,, has a very high affinity transport 
system, it is possible that the rate of B,, import was 
more rapid than that of puromycin, resulting in a de- 
layed effect of puromycin. In contrast, western analysis 
permits a more direct evaluation of methionine syn- 
thase levels, and demonstrates unambiguously that a 
new protein synthesis is required for activation by B,,. 
At least two alternative hypotheses can be consid- 
ered to explain the mechanism of B,, induced activa- 
tion of methionine synthase. First, the intracellular B,, 
pool increases upon supplementation of the medium 
and a higher proportion of newly synthesized methio- 
nine synthase is stabilized by binding cofactor. While 
our data do not rule this out, it seems unlikely since the 
levels of holoenzyme do not change significantly in 
most cell lines. For example 66% of methionine syn- 
thase in Cosy cells is present in the holoenzyme form 
regardless of whether or not the medium is supple- 
mented with the cofactor. If stabilization of methionine 
synthase by an increased intracellular B,, pool re- 
sulted in the increase in its steady-state levels, the 
percentage of holoenzyme would have been expected to 
be increased. 
Alternatively, methionine synthase could be transla- 
tionally regulated by its cofactor. Two other folate- 
dependent enzymes, dihydrofolate reductase and thy- 
midylate synthase (22-24), bind to their own mRNAs. 
This represses translation and represents a form of 
autoregulation. Binding of the nucleotide substrate 
(dUMP in thymidylate synthase) or cofactor (NADPH 
in dihydrofolate reductase) competes with binding for 
mRNA and alleviates translation inhibition. This has 
led to the suggestion that the nucleotide binding do- 
mains of RNA-binding proteins may have acquired en- 
zymatic activity (or the converse) during evolution (25). 
It is interesting to note that B,, also has a nucleotide 
moiety, with an unusual base, dimethylbenzimidazole, 
that is appended from ring D of the corrin macrocycle. 
Vitamin B,, has been shown to mediate repression of 
gene expression in E. coli and in Salmonella typhi- 
murium. In the latter organism, expression of the cob 
operon involved in the de novo biosynthesis of B,, is 
repressed (26-28). In both E. coli and in S.  typhi- 
murium, B,, represses the btuB gene product encoding 
an outer membrane B12 transport protein (29,30). Stud- 
ies on the mechanism of this repression reveal that it is 
mediated postranscriptionally (31). A 25 bp long regu- 
latory sequence designated as the B,, box is located 
-80-110 bp upstream of the initiation codon, and has 
been suggested to constitute the binding site of B,, 
itself or a B,, responsive protein (27). In addition, a 
second common element observed in these transcripts 
is the presence of sequences in the leader with the 
potential to form an RNA hairpin which sequesters the 
RNA binding site. In the presence of B,, an RNA hair- 
pin forms with inhibits translation initiation of the 
cbiA gene in S.  typhimurium (28). Since the regulatory 
elements for translation are distinct in prokaryotes 
and eukaryotes, it is not surprising that a consensus 
B,, box is not observed in the human methionine syn- 
thase cDNA. 
In summary, our data exclude both conversion of 
apomethionine synthase to holoenzyme and transcrip- 
tional activation as explanations for the observed in- 
duction of methionine synthase activity by its cofactor, 
B,,. Instead, our data demonstrate that induction of 
methionine synthase activity correlates with increased 
levels of protein, and is therefore exerted a t  a posttran- 
scriptional level. Elucidation of the mechanism of B,,- 
mediated posttranscriptional regulation will be the 
subject of future investigation. 
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